Gene: [00.0/ATQL3] antiquitin-like 3; — Gene: [00.0/G6PT3] glucose-6-phosphatase, transport (glucose) protein 3; [GSD1d ]


  • Gene: [00.0/ATQL3] antiquitin-like 3;
  • Gene: [00.0/ATQL4] antiquitin-like 4;
  • Gene: [00.0/AUH] AU RNA-binding protein/enoyl-CoA hydratase;
  • Gene: [00.0/AXIN2] axin 2;
  • Gene: [00.0/AZGP2] alpha-2-glycoprotein 1, zinc pseudogene 2; [AZGP1P2 ]
  • Gene: [00.0/BAAT] bile acid CoA:amino acid N-acyltransferase (glycine N-choloyltransferase);
  • Gene: [00.0/BAD] BCL2-antagonist of cell death; transforming protein BCL2-like 8; B-cell chronic lymphatic leukemia 2 (B-CLL: lymphoma 2)-like 8; [BCL2L8 ]
  • Gene: [00.0/BAGE] B melanoma antigen;
  • Gene: [00.0/BC200] brain cytoplasmic RNA 200;
  • Gene: [00.0/BCH] benign chorea;
  • Gene: [00.0/BCL2L1] transforming protein BCL2-like 1; B-cell chronic lymphatic leukemia 2 (B-CLL: lymphoma 2)-like 1; [BCL-X ]
  • Gene: [00.0/BDH] 3-hydroxybutyrate dehydrogenase (heart, mitochondrial);
  • Gene: [00.0/BHMT] betaine-homocysteine S-methyltransferase;
  • Gene: [00.0/BICD1] bicaudal D (Drosophila) homolog 1;
  • Gene: [00.0/BID] BH3 interacting domain death agonist;
  • Gene: [00.0/BIK] BCL2-interacting killer (apoptosis-inducing); [NBK ]
  • Gene: [00.0/BL11] B-cell activation, 45kDa cell-surface glycoprotein, Ig superfamily; antigen CD83; cell surface protein HP15; [CD83 HP15 ]
  • Gene: [00.0/BLR1] Burkitt lymphoma receptor 1, GTP-binding protein;
  • Gene: [00.0/BMP3B] bone morphogenetic protein 3B; growth differentiation factor 10; [GDF10 ]
  • Gene: [00.0/BMP8] bone morphogenetic protein 8 (osteogenic protein 2); [OP2 ]
  • Gene: [00.0/BMPR1B] bone morphogenetic protein receptor, type IB; [ALK6 ]
  • Gene: [00.0/BMPR2] bone morphogenetic protein receptor, type II (serine/threonine kinase); [BRK-3 T-ALK ]
  • Gene: [00.0/BNIP1] BCL2/adenovirus E1B 19kD-interacting protein 1;
  • Gene: [00.0/BNIP2] BCL2/adenovirus E1B 19kD-interacting protein 2;
  • Gene: [00.0/BNIP3L] BCL2/adenovirus E1B 19kD-interacting protein 3-like;
  • Gene: [00.0/BNIP3] BCL2/adenovirus E1B 19kD-interacting protein 3;
  • Gene: [00.0/BOK] BCL2-related ovarian killer; [BCL2L9 ]
  • Gene: [00.0/BONZO] G protein-coupled receptor Bonzo; [STRL33 ]
  • Gene: [00.0/BP1433TA] brain protein 14-3-3, tau subtype; [HS1 ]
  • Gene: [00.0/BP1433TH] brain protein 14-3-3, theta subtype; stratifin; [c9112 HME1 ]
  • Gene: [00.0/BPHL] biphenyl hydrolase-like (serine hydrolase);
  • Gene: [00.0/BPLP] basic proline-rich lacrimal protein;
  • Gene: [00.0/BRF2] butyrate response factor 2 (EGF-response factor 2); [ERF2 TIS11D ]
  • Gene: [00.0/BRK] breast tumor kinase (non-receptor protein tyrosine kinase expressed in breast);
  • Gene: [00.0/BRRN1] barren (Drosophila) homolog 1;
  • Gene: [00.0/BTEB2] basic transcription element binding protein 2;
  • Gene: [00.0/BTF3L2] basic transcription factor 3, like 2 (lambda h23);
  • Gene: [00.0/BTF3L3] basic transcription factor 3, like 3 (lambda h33);
  • Gene: [00.0/BTF3P1] basic transcription factor 3, pseudogene 1 (lambda h16); [HUMBTFA ]
  • Gene: [00.0/BTG3] B-cell translocation gene 3, anti-proliferative; [TOB5 ]
  • Gene: [00.0/BTS1] bladder tumor susceptibility 1;
  • Gene: [00.0/C1QC] complement component 1, q subcomponent, c polypeptide;
  • Gene: [00.0/C3AR1] complement component 3a receptor 1;
  • Gene: [00.0/CA10] carbonic anhydrase X;
  • Gene: [00.0/CA11] carbonic anhydrase XI;
  • Gene: [00.0/CAF1B] chromatin assembly factor 2, p150 subunit;
  • Gene: [00.0/CAL1H] calpactin I, heavy polypeptide (p36);
  • Gene: [00.0/CALM1P1] calmodulin 1 (phosphorylase kinase, delta) pseudogene 1;
  • Gene: [00.0/CALM1P2] calmodulin 1 (phosphorylase kinase, delta) pseudogene 2;
  • Gene: [00.0/CALM2P2] calmodulin 2 (phosphorylase kinase, delta) pseudogene 2;
  • Gene: [00.0/CALM2P3] calmodulin 2 (phosphorylase kinase, delta) pseudogene 3;
  • Gene: [00.0/CALM2P4] calmodulin 2 (phosphorylase kinase, delta) pseudogene 4;
  • Gene: [00.0/CALU] calumenin;
  • Gene: [00.0/CAMK1] calcium/calmodulin-dependent protein kinase (CaM kinase) 1;
  • Gene: [00.0/CAMK2A] calcium/calmodulin-dependent protein kinase (CaM kinase) 2 alpha;
  • Gene: [00.0/CAMK2D] calcium/calmodulin-dependent protein kinase (CaM kinase) 2 delta;
  • Gene: [00.0/CAP1] adenylyl cyclase-associated protein 1 (CAP), yeast homolog;
  • Gene: [00.0/CAP2] adenylyl cyclase-associated protein 2 (CAP), yeast homolog;
  • Gene: [00.0/CAPN5] calpain 5;
  • Gene: [00.0/CAPN6] calpain 6;
  • Gene: [00.0/CAPZA1] capping protein (actin filament) muscle Z-line, alpha 1;
  • Gene: [00.0/CARD1] cardiac autoantigen 1, 145kD;
  • Gene: [00.0/CARD2] cardiac autoantigen 2, 120kD;
  • Gene: [00.0/CARD3] cardiac autoantigen 3, 138kD;
  • Gene: [00.0/CASP8] caspase 8, apoptosis-related cysteine protease;
  • Gene: [00.0/CASP9] caspase 9, apoptosis-related cysteine protease;
  • Gene: [00.0/CATHL1L] cathelicidin 1 (cyclic dodecapeptide, bactenin 1)-like;
  • Gene: [00.0/CATHL1] cathelicidin 1 (cyclic dodecapeptide, bactenin 1);
  • Gene: [00.0/CATHL2] cathelicidin 2 (bactenin 5);
  • Gene: [00.0/CATHL3] cathelicidin 3 (bactenin 7);
  • Gene: [00.0/CATHL4] cathelicidin 4 (indolicidin);
  • Gene: [00.0/CATHL5] cathelicidin 5;
  • Gene: [00.0/CATHL6] cathelicidin 6;
  • Gene: [00.0/CATHLP] cathelicidin pseudogene;
  • Gene: [00.0/CATR1] CATR tumorigenic conversion 1; [CATR1.3 ]
  • Gene: [00.0/CAV1] caveolin 1 (caveolae protein, 22kD); [CAV ]
  • Gene: [00.0/CAV2] caveolin 2 (caveolae protein, 20kD);
  • Gene: [00.0/CBLN1] cerebellin 1;
  • Gene: [00.0/CBP1] collagen-binding protein 1 (colligin 1; gp46); colligin 1 (collagen binding protein 1); heat shock 47kD protein (collagen binding protein; colligin 1);
  • Gene: [00.0/CBR3] carbonyl reductase 3;
  • Gene: [00.0/CCI] cholesterol crystallization inhibitor;
  • Gene: [00.0/CCNB2] cyclin B2 (G2/mitotic specific);
  • Gene: [00.0/CCNG2] cyclin G2;
  • Gene: [00.0/CCNL1] cyclin-like 1;
  • Gene: [00.0/CCNT2] cyclin T2 (CDK9-associated C-type cyclin);
  • Gene: [00.0/CCT6] chaperonin containing T-complex subunit 6 (zeta); T-complex homolog TCP-20; histidine transport regulator 3; [TCP20 HTR3 ]
  • Gene: [00.0/CD24L3] antigen CD24-like 3;
  • Gene: [00.0/CD24L4] antigen CD24-like 4;
  • Gene: [00.0/CD68] antigen CD68 (gp110; macrosialin);
  • Gene: [00.0/CDC10] cell division cycle 10 (homologous to CDC10 of S.cerevisiae);
  • Gene: [00.0/CDC4L] cell division cycle 4-like;
  • Gene: [00.0/CDH10] cadherin 10 (T2-cadherin);
  • Gene: [00.0/CDH11] cadherin 11 (OB-cadherin, osteoblast);
  • Gene: [00.0/CDH18] cadherin 18; [CDH14 ]
  • Gene: [00.0/CDH19] cadherin 19 (fibroblast cadherin 1); [FIB1 ]
  • Gene: [00.0/CDH20] cadherin 20 (fibroblast cadherin 2); [FIB2 ]
  • Gene: [00.0/CDH21] cadherin 21 (fibroblast cadherin 3); [FIB3 ]
  • Gene: [00.0/CDH4] cadherin 4 (R-cadherin; retinal);
  • Gene: [00.0/CDH6] cadherin 6 (K-cadherin; fetal kidney);
  • Gene: [00.0/CDH9] cadherin 9 (T1-cadherin);
  • Gene: [00.0/CDK8] cyclin-dependent kinase 8;
  • Gene: [00.0/CDMP2] cartilage-derived morphogenic protein 2;
  • Gene: [00.0/CDO1] cysteine dioxygenase type I;
  • Gene: [00.0/CDW52] CDW52 antigen (CAMPATH-1 antigen);
  • Gene: [00.0/CEBPG] CCAAT/enhancer binding protein (C/EBP), gamma;
  • Gene: [00.0/CENPA] centromere protein A (autoantigen A; 17kD);
  • Gene: [00.0/CES2] carboxylesterase 2 (liver);
  • Gene: [00.0/CETN2] centrin, EF-hand protein, 2; caltractin 2;
  • Gene: [00.0/CETN3] centrin, EF-hand protein, 3 (CDC31 yeast homolog); [CEN3 ]
  • Gene: [00.0/CFLL1] cofilin-like 1;
  • Gene: [00.0/CFLL2] cofilin-like 2;
  • Gene: [00.0/CFLL3] cofilin-like 3;
  • Gene: [00.0/CFLL4] cofilin-like 4;
  • Gene: [00.0/CGN1] conglutinin;
  • Gene: [00.0/CGRPR1] calcitonin gene-related peptide type 1 receptor;
  • Gene: [00.0/CHED2] congenital hereditary corneal edema of Maumenee (autosomal recessive);
  • Gene: [00.0/CHI3L2] chitinase 3-like 2;
  • Gene: [00.0/CHK] choline kinase;
  • Gene: [00.0/CHRNA6] cholinergic receptor, nicotinic, alpha polypeptide 6;
  • Gene: [00.0/CHRNAL] cholinergic receptor, nicotinic, alpha-plus polypeptide (neuronal); [NACHRNA ]
  • Gene: [00.0/CKS1] cyclin-dependent kinases regulatory subunit 1; CKS1 (S. cerevisiae Cdc28/Cdc2 kinase subunit) homolog 1;
  • Gene: [00.0/CKS2] cyclin-dependent kinases regulatory subunit 2; CKS1 (S. cerevisiae Cdc28/Cdc2 kinase subunit) homolog-2;
  • Gene: [00.0/CLA3] cerebellar ataxia 3 (cerebellar parenchyma disorder 1); [CPD1 ]
  • Gene: [00.0/CLAPA1] clathrin-associated/assembly/adaptor protein, large, alpha 1 (100kD);
  • Gene: [00.0/CLAPA2] clathrin-associated/assembly/adaptor protein, large, alpha 2 (100kD);
  • Gene: [00.0/CLAPB2] clathrin-associated/assembly/adaptor protein, large, beta 2;
  • Gene: [00.0/CLAPG1] clathrin-associated/assembly/adaptor protein, large, gamma 1;
  • Gene: [00.0/CLAPS1] clathrin-associated/assembly/adaptor protein, small 1 (19kD); [AP19 ]
  • Gene: [00.0/CLAPS2] clathrin-associated/assembly/adaptor protein, small 2 (17kD); [AP17 ]
  • Gene: [00.0/CLCA1] chloride channel, calcium activated, 1; [CaCC ]
  • Gene: [00.0/CLIC1] chloride intracellular channel 1; nuclear chloride ion channel 27; [NCC27 p64CLCP ]
  • Gene: [00.0/CLN4] ceroid-lipofuscinosis, neuronal 4 (adult; Kufs disease);
  • Gene: [00.0/CLN7] ceroid-lipofuscinosis, neuronal 7, late infantile, variant;
  • Gene: [00.0/CMD1G] cardiomyopathy, dilated 1G (autosomal dominant);
  • Gene: [00.0/CMH5] cardiomyopathy, hypertrophic 5;
  • Gene: [00.0/CMKLR1] chemokine-like receptor 1;
  • Gene: [00.0/CMR1A] cardiomyopathy, restrictive 1A (autosomal dominant);
  • Gene: [00.0/CMR2A] cardiomyopathy, restrictive 2A (autosomal recessive);
  • Gene: [00.0/CNA1] cornea plana 1 (autosomal dominant);
  • Gene: [00.0/CNGA2] cyclic nucleotide gated channel alpha 2; cyclic nucleotide gated channel (photoreceptor), cAMP gated 1 (alpha); [CNCA CGN2 ]
  • Gene: [00.0/CNGA3] cyclic nucleotide gated channel alpha 3; cyclic nucleotide gated channel (photoreceptor), cGMP gated 3 (gamma); [CNG3 CNCG3 ]
  • Gene: [00.0/CNGB2] cyclic nucleotide gated channel beta 2; cyclic nucleotide gated channel (photoreceptor), cAMP gated 2 (beta); [CNCA2 ]
  • Gene: [00.0/CNK] cytokine-inducible kinase (proliferation-related kinase);
  • Gene: [00.0/CNR2] cannabinoid receptor 2 (macrophage);
  • Gene: [00.0/COL11A3] collagen, type XI, alpha 3;
  • Gene: [00.0/COL5A3] collagen, type V, alpha 3; [COL5B ]
  • Gene: [00.0/COPB] beta coat protein (coatomer protein complex, subunit beta; 110 kD);
  • Gene: [00.0/COP] clathrin-ordered protein;
  • Gene: [00.0/CORD4] cone-rod dystrophy 4;
  • Gene: [00.0/COT] cot (cancer Osaka thyroid) oncogene; cot proto-oncogene serine/threonine-protein kinase;
  • Gene: [00.0/COX5A] cytochrome c oxidase subunit Va;
  • Gene: [00.0/COX6A1] cytochrome c oxidase subunit VIa polypeptide 1 (liver-specific isoform);
  • Gene: [00.0/COX6BP1] cytochrome c oxidase subunit VIb pseudogene 1;
  • Gene: [00.0/COX6BP2] cytochrome c oxidase subunit VIb pseudogene 2;
  • Gene: [00.0/COX6BP3] cytochrome c oxidase subunit VIb pseudogene 3;
  • Gene: [00.0/COX6BP4] cytochrome c oxidase subunit VIb pseudogene 4;
  • Gene: [00.0/COX6C] cytochrome c oxidase subunit VIc;
  • Gene: [00.0/COX7B] cytochrome c oxidase subunit VIIb;
  • Gene: [00.0/COX7C] cytochrome c oxidase subunit VIIc;
  • Gene: [00.0/CPA2] carboxypeptidase A2 (pancreatic);
  • Gene: [00.0/CPB1] carboxypeptidase B1 (tissue);
  • Gene: [00.0/CPD] carboxypeptidase D;
  • Gene: [00.0/CPETR] clostridium perfringens enterotoxin receptor (high-affinity); [CPETR1 CPER ]
  • Gene: [00.0/CPN1] carboxypeptidase N, polypeptide 1, 50kD;
  • Gene: [00.0/CPN2] carboxypeptidase N, polypeptide 2, 83kD; arginine carboxypeptidase (carboxypeptidase N);
  • Gene: [00.0/CRTL2] cartilage linking protein 2;
  • Gene: [00.0/CRY2] cryptochrome 2 (photolyase-like); [PHLL2 ]
  • Gene: [00.0/CRYZP1] crystallin, zeta polypeptide pseudogene 1; quinone reductase pseudogene 1;
  • Gene: [00.0/CSPG3] chondroitin sulfate proteoglycan 3 (neurocan); [NCAN ]
  • Gene: [00.0/CSTF1] cleavage stimulation factor, 3' pre-RNA, subunit 1, 50kD;
  • Gene: [00.0/CSTF2] cleavage stimulation factor, 3' pre-RNA, subunit 2, 64kD;
  • Gene: [00.0/CSTF3] cleavage stimulation factor, 3' pre-RNA, subunit 3, 77kD;
  • Gene: [00.0/CTAA1] cataract, anterior polar 1; [CAP ]
  • Gene: [00.0/CTF1] cardiotrophin 1;
  • Gene: [00.0/CTNND2] catenin (cadherin-associated protein), delta 2;
  • Gene: [00.0/CTNNG] catenin (cadherin-associated protein), gamma (80kD);
  • Gene: [00.0/CTRB2] chymotrypsinogen B2;
  • Gene: [00.0/CTS1] carpal tunnel syndrome 1;
  • Gene: [00.0/CTSO] cathepsin O;
  • Gene: [00.0/CTSW] cathepsin W;
  • Gene: [00.0/CXADR] coxsackie virus and adenovirus receptor (46kD); cell surface protein CAR; [CAR ]
  • Gene: [00.0/CYB5P2] cytochrome b-5 pseudogene 2;
  • Gene: [00.0/CYB5P5] cytochrome b-5 pseudogene 5;
  • Gene: [00.0/CYCL1] cylicin 1 (basic protein of sperm head cytoskeleton); [CYL1 ]
  • Gene: [00.0/CYCL2] cylicin 2 (basic protein of sperm head cytoskeleton); [CYL2 ]
  • Gene: [00.0/CYP26A1] cytochrome P450, subfamily XXVIA (retinoic acid hydrolase), polypeptide 1;
  • Gene: [00.0/CYP2C17] cytochrome P450, subfamily IIC (mephenytoin 4-hydroxylase), polypeptide 17;
  • Gene: [00.0/CYP2G1] cytochrome P450, subfamily IIG (olfactory-specific), polypeptide 1;
  • Gene: [00.0/CYP2J2] cytochrome P450, subfamily IIJ (arachidonic acid epoxygenase), polypeptide 2;
  • Gene: [00.0/CYP3A5P1] cytochrome P450, subfamily IIIA (niphedipine oxidase), polypeptide 5 pseudogene 1;
  • Gene: [00.0/CYP4F2] cytochrome P450, subfamily IVF, polypeptide 2; leukotriene B4 omega hydroxylase;
  • Gene: [00.0/CZP2] cataract, zonular pulverulent 2; [CAE2 ]
  • Gene: [00.0/DARS] aspartyl-tRNA synthetase;
  • Gene: [00.0/DASOX] D-aspartate oxidase;
  • Gene: [00.0/DCTD] dCMP deaminase;
  • Gene: [00.0/DCTN2] dynactin 2 (p50); [RBP50 ]
  • Gene: [00.0/DDT] D-dopachrome tautomerase (phenylpyruvate tautomerase II);
  • Gene: [00.0/DDX7] DEAD/H (Asp-Glu-Ala-Asp/His) box polypeptide 7 (RNA helicase, 52kD);
  • Gene: [00.0/DDX8] DEAD/H (Asp-Glu-Ala-Asp/His) box polypeptide 8 (RNA helicase); helicase, RNA, nuclear 4; [HLR4 HRH1 ]
  • Gene: [00.0/DDX9] DEAD/H (Asp-Glu-Ala-Asp/His) box polypeptide 9 (RNA helicase A);
  • Gene: [00.0/DECR] 2,4-dienoyl-CoA reductase (NADPH); 2,4-dienoyl-Coa reductase deficiency;
  • Gene: [00.0/DFFA] DNA fragmentation factor, alpha (45kD); [DFF1 ]
  • Gene: [00.0/DFFB] DNA fragmentation factor, beta (40kD); [DFF2 ]
  • Gene: [00.0/DFNA14] deafness, autosomal dominant 14;
  • Gene: [00.0/DFNA16] deafness, autosomal dominant 16;
  • Gene: [00.0/DFNB10] deafness, autosomal recessive 10;
  • Gene: [00.0/DFNB14] deafness, autosomal recessive 14;
  • Gene: [00.0/DFNB15] deafness, autosomal recessive 15;
  • Gene: [00.0/DFNB19] deafness, autosomal recessive 19;
  • Gene: [00.0/DF] complement component D (adipsin, C3 convertase activator);
  • Gene: [00.0/DGKB] diacylglycerol kinase, beta (90kD);
  • Gene: [00.0/DGKD] diacylglycerol kinase, delta (130kD);
  • Gene: [00.0/DGKE] diacylglycerol kinase, epsilon (64kD);
  • Gene: [00.0/DHCR24] 24-dehydrocholesterol reductase;
  • Gene: [00.0/DIA2] diaphorase 2 (NADPH-dependent);
  • Gene: [00.0/DIA3] diaphorase 3 (sperm);
  • Gene: [00.0/DIH1] diaphragmatic hernia 1;
  • Gene: [00.0/DIO2] deiodinase, iodothyronine type II; thyroxine deiodinase type II (selenoprotein);
  • Gene: [00.0/DIO3] deiodinase, iodothyronine type III; thyroxine deiodinase type III (selenoprotein);
  • Gene: [00.0/DLG2] discs, large (Drosophila) homolog 2 (chapsyn-110);
  • Gene: [00.0/DLSTP] dihydrolipoamide S-succinyltransferase pseudogene (E2 component of 2-oxo-glutarate complex);
  • Gene: [00.0/DMC1H] disrupted meiotic cDNA 1 homolog;
  • Gene: [00.0/DNAH13] dynein, axonemal, heavy polypeptide 13;
  • Gene: [00.0/DNAH14] dynein, axonemal, heavy polypeptide 14;
  • Gene: [00.0/DNAH1] dynein, axonemal, heavy polypeptide 1;
  • Gene: [00.0/DNAH2] dynein, axonemal, heavy polypeptide 2;
  • Gene: [00.0/DNAH3] dynein, axonemal, heavy polypeptide 3;
  • Gene: [00.0/DNAH5] dynein, axonemal, heavy polypeptide 5;
  • Gene: [00.0/DNAH6] dynein, axonemal, heavy polypeptide 6;
  • Gene: [00.0/DNAH8] dynein, axonemal, heavy polypeptide 8;
  • Gene: [00.0/DNAH9] dynein, axonemal, heavy polypeptide 9;
  • Gene: [00.0/DNCH1] dynein, cytoplasmic, heavy polypeptide 1; [DNEC1 ]
  • Gene: [00.0/DNCH2] dynein, cytoplasmic, heavy polypeptide 2;
  • Gene: [00.0/DNCI1] dynein, cytoplasmic, intermediate polypeptide 1;
  • Gene: [00.0/DNCI2] dynein, cytoplasmic, intermediate polypeptide 2;
  • Gene: [00.0/DNCLI2] dynein, cytoplasmic, light intermediate polypeptide 2;
  • Gene: [00.0/DNM2] dynamin 2;
  • Gene: [00.0/DOCK2] dedicator of cyto-kinesis 2 (similar to a major CRK-binding protein DOCK180); [KIAA0209 ]
  • Gene: [00.0/DOCK3] dedicator of cyto-kinesis 3 (similar to a major CRK-binding protein DOCK180); [KIAA0299 ]
  • Gene: [00.0/DOK1] docking protein 1 (downstream of tyrosine kinase 1); [p62dok ]
  • Gene: [00.0/DO] Dombrock blood group;
  • Gene: [00.0/DPAGT2] dolichyl-phosphate alpha-N-acetylglucosaminyltransferase 2 (GlcNAc-1-P transferase);
  • Gene: [00.0/DPH2L2] diptheria toxin resistance protein required for diphthamide biosynthesis (Saccharomyces)-like 2;
  • Gene: [00.0/DPYSL3] dihydropyrimidinase-like 3; unc-33-like phosphoprotein (C. elegans) homolog; [DRP-3 ULIP ]
  • Gene: [00.0/DPYSL4] dihydropyrimidinase-like 4; [ULIP4 ]
  • Gene: [00.0/DPYS] dihydropyrimidinase (DHPase; hydantoinase); dihydropyrimidinuria (dihydropyrimidinase deficiency);
  • Gene: [00.0/DR4] death receptor 4; cytotoxic ligand TRAIL receptor 1; [TRAIL-R1 ]
  • Gene: [00.0/DRIL1] dead ringer (Drosophila)-like 1;
  • Gene: [00.0/DSIPI] delta sleep inducing peptide, immunoreactor; [DIP ]
  • Gene: [00.0/DTX1] deltex (Drosophila) homolog 1; [hDx-1 ]
  • Gene: [00.0/DWS] Dandy-Walker syndrome;
  • Gene: [00.0/DYT2] dystonia 2, torsion (autosomal recessive);
  • Gene: [00.0/DYT4] dystonia 4, torsion (autosomal dominant);
  • Gene: [00.0/DYX1] dyslexia (reading disability), specific, 1;
  • Gene: [00.0/E2F5] E2F transcription factor 5, p107/p130-binding; [E2F-6 ]
  • Gene: [00.0/E2F6] E2F transcription factor 6; [E2F-6 ]
  • Gene: [00.0/E3B1] eps8 SH3 domain binding protein;
  • Gene: [00.0/E4F1] E4F transcription factor 1;
  • Gene: [00.0/EBI2] Epstein-Barr virus induced gene 2; G protein-coupled receptor, lymphocyte-specific 2;
  • Gene: [00.0/EBP] phenylalkylamine Ca2+ antagonist (emopamil) binding protein;
  • Gene: [00.0/EBR4] epidermolysis bullosa 4, pseudojunctional (intraepidermal);
  • Gene: [00.0/ECM] endothelial cell multimerin;
  • Gene: [00.0/ECT] epilepsy, centrotemporal;
  • Gene: [00.0/ED4] ectodermal dysplasia 4 (Margarita Island type);
  • Gene: [00.0/EDG2] endothelial differentiation, lysophosphatidic acid G-protein-coupled receptor, 2; G protein-coupled receptor, endothelial differentiation gene 2; ventricular zone gene 1; [vzg-1 rec.1.3 ]
  • Gene: [00.0/EDM3] epiphyseal dysplasia, multiple 3;
  • Gene: [00.0/EDR1] early development regulator 1 (homolog of polyhomeotic 1); [HPH1 ]
  • Gene: [00.0/EDR2] early development regulator 2 (homolog of polyhomeotic 2); [HPH2 ]
  • Gene: [00.0/ED] ectodermal dysplasia, anhidrotic (hypohydrotic) 2, autosomal recessive; [ARHED EDA2 ]
  • Gene: [00.0/EEA1] early endosome antigen 1; early endosome-associated protein;
  • Gene: [00.0/EEF1A1] eukaryotic translation elongation factor 1 alpha 1; [EF1A EEF1A ]
  • Gene: [00.0/EEF1A2] eukaryotic translation elongation factor 1 alpha 2 (statin S1); [STN ]
  • Gene: [00.0/EEF1AL10] eukaryotic translation elongation factor 1 alpha-like 10;
  • Gene: [00.0/EEF1AL11] eukaryotic translation elongation factor 1 alpha-like 11;
  • Gene: [00.0/EEF1AL12] eukaryotic translation elongation factor 1 alpha-like 12;
  • Gene: [00.0/EEF1AL13] eukaryotic translation elongation factor 1 alpha-like 13;
  • Gene: [00.0/EEF1AL2] eukaryotic translation elongation factor 1 alpha-like 2;
  • Gene: [00.0/EEF1AL3] eukaryotic translation elongation factor 1 alpha-like 3;
  • Gene: [00.0/EEF1AL4] eukaryotic translation elongation factor 1 alpha-like 4;
  • Gene: [00.0/EEF1AL5] eukaryotic translation elongation factor 1 alpha-like 5;
  • Gene: [00.0/EEF1AL6] eukaryotic translation elongation factor 1 alpha-like 6;
  • Gene: [00.0/EEF1AL7] eukaryotic translation elongation factor 1 alpha-like 7;
  • Gene: [00.0/EEF1AL8] eukaryotic translation elongation factor 1 alpha-like 8;
  • Gene: [00.0/EEF1AL9] eukaryotic translation elongation factor 1 alpha-like 9;
  • Gene: [00.0/EEF1D] eukaryotic translation elongation factor 1 delta; guanine nucleotide exchange protein;
  • Gene: [00.0/EEF1G] eukaryotic translation elongation factor 1 gamma;
  • Gene: [00.0/EFNA2] ephrin-A2; eph-related receptor tyrosine kinase ligand 6; [EPLG6 ELF-1 ]
  • Gene: [00.0/EFNA5] ephrin-A5; eph-related receptor tyrosine kinase ligand 7; [EPLG7 AF1 ]
  • Gene: [00.0/EFTS] translational elongation factor Ts, mitochondrial;
  • Gene: [00.0/EGFL1] EGF-like-domain, multiple 1; [MEGF2 ]
  • Gene: [00.0/EGFL2] EGF-like-domain, multiple 2 (similar to cadherin-related tumor suppressor hFat protein); [MEGF3 ]
  • Gene: [00.0/EGFL3] EGF-like-domain, multiple 3; [MEGF6 ]
  • Gene: [00.0/EGFL4] EGF-like-domain, multiple 4; [MEGF8 ]
  • Gene: [00.0/EGFL5] EGF-like-domain, multiple 5; [MEGF9 ]
  • Gene: [00.0/EHK2] EPH homology kinase 2 (tyrosine-protein kinase receptor EHK2);
  • Gene: [00.0/EIF1] eukaryotic translation initiation factor 1;
  • Gene: [00.0/EIF2B1] eukaryotic translation initiation factor 2B, subunit 1 (alpha); [EIF2B ]
  • Gene: [00.0/EIF2B3] eukaryotic translation initiation factor 2B, subunit 3 (gamma, 58kD);
  • Gene: [00.0/EIF2B4] eukaryotic translation initiation factor 2B, subunit 4 (delta, 67kD);
  • Gene: [00.0/EIF2B5] eukaryotic translation initiation factor 2B, subunit 5 (epsilon, 82kD);
  • Gene: [00.0/EIF2S1] eukaryotic translation initiation factor 2, subunit 1 (alpha, 35kD); eukaryotic translation initiation factor 2A; [EIF2A EIF2 ]
  • Gene: [00.0/EIF2S2] eukaryotic translation initiation factor 2, subunit 2 (beta, 38kD); [EIF2 ]
  • Gene: [00.0/EIF3S1] eukaryotic translation initiation factor 3, subunit 1 (alpha, 35kD);
  • Gene: [00.0/EIF3S2] eukaryotic translation initiation factor 3, subunit 2 (beta, 36kD); eukaryotic translation initiation factor 3D (p36); TGF-beta receptor interacting protein 1; [EIF3D EIF3 ]
  • Gene: [00.0/EIF3S3] eukaryotic translation initiation factor 3, subunit 3 (gamma, 40kD);
  • Gene: [00.0/EIF3S4] eukaryotic translation initiation factor 3, subunit 4 (delta, 44kD);
  • Gene: [00.0/EIF3S5] eukaryotic translation initiation factor 3, subunit 5 (epsilon, 47kD);
  • Gene: [00.0/EIF3S7] eukaryotic translation initiation factor 3, subunit 7 (zeta, 66/67kD);
  • Gene: [00.0/EIF3S8] eukaryotic translation initiation factor 3, subunit 8 (110kD);
  • Gene: [00.0/EIF3S9] eukaryotic translation initiation factor 3, subunit 9 (eta, 116kD); eukaryotic translation initiation factor 3B (p116; human homolog of yeast Prt1 gene); [EIF3B Prt1 ]
  • Gene: [00.0/EIF4B] eukaryotic translation initiation factor 4B;
  • Gene: [00.0/EIF4] eukaryotic translation initiation factor 4;
  • Gene: [00.0/EIF5] eukaryotic translation initiation factor 5;
  • Gene: [00.0/ELAVL3] ELAV (embryonic lethal, abnormal vision, Drosophila)-like 3; Hu antigen C; [HUC ]
  • Gene: [00.0/ELF1] E74-like factor 1 (ets domain transcription factor);
  • Gene: [00.0/ELF2] E74-like factor 2 (ets domain transcription factor);
  • Gene: [00.0/ELF4] E74-like factor 4 (ets domain transcription factor); [MEF ]
  • Gene: [00.0/ELL2] RNA polymerase II elongation factor ELL2;
  • Gene: [00.0/ELNR1] elastin receptor 1 (67kD);
  • Gene: [00.0/EMP1] epithelial membrane protein 1 (tumor-associated); [TMP B4B ]
  • Gene: [00.0/EMP2] epithelial membrane protein 2 (tumor-associated); [XMP ]
  • Gene: [00.0/EMP3] epithelial membrane protein 3 (tumor-associated); [YMP ]
  • Gene: [00.0/ENO1L1] enolase 1, (alpha)-like 1;
  • Gene: [00.0/ENPEP] glutamyl aminopeptidase (aminopeptidase A);
  • Gene: [00.0/EPAS1] endothelial PAS domain protein 1; [MOP2 ]
  • Gene: [00.0/EPHA4] ephrin receptor EphA4; protein tyrosine kinase TYRO1; human embryo kinase 8;
  • Gene: [00.0/EPHA5] ephrin receptor EphA5; EPH homology kinase 1 (tyrosine-protein kinase receptor EHK1); human embryo kinase 7;
  • Gene: [00.0/EPHA7] ephrin receptor EphA7; EPH homology kinase 3 (tyrosine-protein kinase receptor EHK3); human embryo kinase 11;
  • Gene: [00.0/EPX] eosinophil peroxidase; hereditary eosinophil peroxidase deficiency (Presentey anomaly; MIM:261500);
  • Gene: [00.0/ERCC8] excision repair cross-complementing rodent repair deficiency, complementation group 8;
  • Gene: [00.0/EREG] epiregulin (EGF-related growth regulating peptide);
  • Gene: [00.0/ERVH2] endogenous retroviral sequence, HTLV-1 related 2; [HRES2 ]
  • Gene: [00.0/ERVSSAL] endogenous retroviral sequence simian sarcoma-associated-like; simian sarcoma-associated virus 1-like; gibbon ape leukemia virus-related endogenous retroviral element 1-like; [SSAV1L ]
  • Gene: [00.0/ESR2] estrogen receptor 2;
  • Gene: [00.0/ETF1] eukaryotic translation termination factor 1; [ERF ]
  • Gene: [00.0/EYCL2] eye color 2 (central brown); [BEY1 EYCL ]
  • Gene: [00.0/F13A2] coagulation factor XIII, A2 polypeptide;
  • Gene: [00.0/F13A3] coagulation factor XIII, A3 polypeptide;
  • Gene: [00.0/F1L] fibrinogen-like 1 (pT49 protein); [FGL1 HFREP-1 ]
  • Gene: [00.0/F2RL2] coagulation factor II (thrombin) receptor-like 2; proteinase activated receptor 3; [PAR3 ]
  • Gene: [00.0/FAAH] fatty acid amide hydrolase;
  • Gene: [00.0/FAB4] fatty acid binding protein 4, adipocyte; [FABP4 ]
  • Gene: [00.0/FAB5] fatty acid binding protein 5, epidermal (psoriasis-associated); [FABP5 ]
  • Gene: [00.0/FAB7] fatty acid binding protein 7, brain; [FABP7 B-FABP ]
  • Gene: [00.0/FAB9] fatty acid binding protein 9, testis; [FABP9 PERF ]
  • Gene: [00.0/FACL4] fatty-acid-CoA ligase, long-chain 4;
  • Gene: [00.0/FADD] Fas-associating protein with death domain; [MORT1 ]
  • Gene: [00.0/FANCB] Fanconi anemia, complementation group B gene; Fanconi anemia, complementation group B; Fanconi pancytopenia, type 2; [FAB FA2 ]
  • Gene: [00.0/FANCE] Fanconi anemia, complementation group E gene; Fanconi anemia, complementation group E; Fanconi pancytopenia, type 5; [FACE FAE FA5 ]
  • Gene: [00.0/FANCF] Fanconi anemia, complementation group F gene; Fanconi anemia, complementation group F; [FAF ]
  • Gene: [00.0/FANCG] Fanconi anemia, complementation group G gene; Fanconi anemia, complementation group G; [FAG ]
  • Gene: [00.0/FANCH] Fanconi anemia, complementation group H gene; Fanconi anemia, complementation group H; [FAH ]
  • Gene: [00.0/FBL] fibrillarin;
  • Gene: [00.0/FBP2] fructose-1,6-bisphosphatase 2;
  • Gene: [00.0/FCGBP] Fc fragment of IgG binding protein;
  • Gene: [00.0/FCGR2C] Fc fragment of IgG, low affinity IIc, receptor for (CD32);
  • Gene: [00.0/FDPS] farnesyldiphosphate synthetase (dimethylallyltransferase; EC:2.5.1.1); farnesyldiphosphate synthetase (geranyl-trans-transferase; EC:2.5.1.10);
  • Gene: [00.0/FDX2] ferredoxin 2;
  • Gene: [00.0/FGFR6] fibroblast growth factor receptor 6;
  • Gene: [00.0/FGS2] FG syndrome 2;
  • Gene: [00.0/FHL2] four and a half LIM domains 2; [DRAL SLIM3 ]
  • Gene: [00.0/FHL3] four and a half LIM domains 3; [SLIM2 ]
  • Gene: [00.0/FKBP1L] FK506-binding protein 1-like;
  • Gene: [00.0/FKBP1P1] FK506-binding protein 1 pseudogene 1;
  • Gene: [00.0/FKBP1P2] FK506-binding protein 1 pseudogene 2;
  • Gene: [00.0/FKBP1P3] FK506-binding protein 1 pseudogene 3;
  • Gene: [00.0/FKBP1P4] FK506-binding protein 1 pseudogene 4;
  • Gene: [00.0/FKBP3] FK506-binding protein 3 (25kD);
  • Gene: [00.0/FKBP4] FK506-binding protein 4 (59kD);
  • Gene: [00.0/FKBP5] FK506-binding protein 5 (51kD);
  • Gene: [00.0/FKHL11] forkhead (Drosophila)-like 11;
  • Gene: [00.0/FKHL3] forkhead (Drosophila)-like 3;
  • Gene: [00.0/FKHL6] forkhead (Drosophila)-like 6;
  • Gene: [00.0/FLIP] FLICE-inhibitory protein;
  • Gene: [00.0/FLN1L] filamin 1 (actin-binding protein-280)-like; [TAP TABP ]
  • Gene: [00.0/FMR1L2] fragile X-mental retardation 1-like 2;
  • Gene: [00.0/FOLH2] folate hydrolase 2;
  • Gene: [00.0/FOLHP] folate hydrolase pseudogene;
  • Gene: [00.0/FRAP2] FK506 binding protein 12-rapamycin associated protein 2;
  • Gene: [00.0/FRAT1] frequently rearranged in advanced T-cell lymphomas; proto-oncogene FRAT1;
  • Gene: [00.0/FRDA2] Friedreich ataxia 2;
  • Gene: [00.0/FRK] FYN-related kinase; protein tyrosine kinase FRK;
  • Gene: [00.0/FRP] follistatin-related protein;
  • Gene: [00.0/FSHMD1B] facioscapulohumeral muscular dystrophy 1B;
  • Gene: [00.0/FSP] fibroblast secretory protein;
  • Gene: [00.0/FST] follistatin (activin-binding);
  • Gene: [00.0/FTHP2] ferritin, heavy polypeptide pseudogene 2;
  • Gene: [00.0/FTHP3] ferritin, heavy polypeptide pseudogene 3;
  • Gene: [00.0/FXR2] fragile X mental retardation gene - autosomal homolog 2;
  • Gene: [00.0/FYB] FYN-binding protein (FYB-120/130; SLAP-130); [SLAP130 ]
  • Gene: [00.0/FZD4] frizzled (Drosophila) homolog 4;
  • Gene: [00.0/FZD8] frizzled (Drosophila) homolog 8;
  • Gene: [00.0/G0S2] G0 to G1 switch regulatory 2, 11kD;
  • Gene: [00.0/G6PR] glucose-6-phosphatase, regulatory; [GSD1aSP ]
  • Gene: [00.0/G6PT2] glucose-6-phosphatase, transport (phosphate/pyrophosphate) protein 2; [GSD1c ]
  • Gene: [00.0/G6PT3] glucose-6-phosphatase, transport (glucose) protein 3; [GSD1d ]